These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21684798

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A unified strategy for the total syntheses of eribulin and a macrolactam analogue of halichondrin B.
    Nicolaou KC, Pan S, Shelke Y, Rigol S, Bao R, Das D, Ye Q.
    Proc Natl Acad Sci U S A; 2022 Aug 09; 119(32):e2208938119. PubMed ID: 35930662
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Molecular and cellular mechanisms of fingolimod action].
    Nikitin AV.
    Antibiot Khimioter; 2013 Aug 09; 58(11-12):38-42. PubMed ID: 24734428
    [Abstract] [Full Text] [Related]

  • 25. Insights into drug discovery from natural products through structural modification.
    Chen J, Li W, Yao H, Xu J.
    Fitoterapia; 2015 Jun 09; 103():231-41. PubMed ID: 25917513
    [Abstract] [Full Text] [Related]

  • 26. Inhibitors of cerebroside metabolism.
    Radin NS, Vunnam RR.
    Methods Enzymol; 1981 Jun 09; 72():673-84. PubMed ID: 6458753
    [No Abstract] [Full Text] [Related]

  • 27. Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389.
    Kuznetsov G, Towle MJ, Cheng H, Kawamura T, TenDyke K, Liu D, Kishi Y, Yu MJ, Littlefield BA.
    Cancer Res; 2004 Aug 15; 64(16):5760-6. PubMed ID: 15313917
    [Abstract] [Full Text] [Related]

  • 28. Synthesis of four diastereomers of sclerophytin F and structural reassignment of several sclerophytin natural products.
    Clark JS, Delion L, Farrugia LJ.
    Chemistry; 2015 Mar 16; 21(12):4772-80. PubMed ID: 25663662
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Strategies to diversify natural products for drug discovery.
    Li G, Lou HX.
    Med Res Rev; 2018 Jul 16; 38(4):1255-1294. PubMed ID: 29064108
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Absorption and disposition of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in healthy volunteers: a case of xenobiotic biotransformation following endogenous metabolic pathways.
    Zollinger M, Gschwind HP, Jin Y, Sayer C, Zécri F, Hartmann S.
    Drug Metab Dispos; 2011 Feb 16; 39(2):199-207. PubMed ID: 21045200
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Recent advances in the field of bioactive tetronates.
    Vieweg L, Reichau S, Schobert R, Leadlay PF, Süssmuth RD.
    Nat Prod Rep; 2014 Nov 16; 31(11):1554-84. PubMed ID: 24965099
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Editorial: Marine Natural Products themed issue.
    Nat Prod Rep; 2011 Feb 16; 28(2):181. PubMed ID: 21229158
    [No Abstract] [Full Text] [Related]

  • 40. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K.
    Pharmacol Ther; 2005 Dec 16; 108(3):308-19. PubMed ID: 15951022
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.